The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Deregulated GSK3β activity in colorectal cancer: Its association with tumor cell survival and proliferation
Open accessAbstract
Glycogen synthase kinase 3beta (GSK3beta) reportedly has opposing roles, repressing Wnt/beta-catenin signaling on the one hand but maintaining cell survival and proliferation through the NF-kappaB pathway on the other. The present investigation was undertaken to clarify the roles of GSK3beta in human cancer. In colon cancer cell lines and colorectal cancer patients, levels of GSK3beta expression and amounts of its active form were higher in tumor cells than in their normal counterparts; these findings were independent of nuclear accumulation of beta-catenin oncoprotein in the tumor cells. Inhibition of GSK3beta activity by phosphorylation was defective in colorectal cancers but preserved in non-neoplastic cells and tissues. Strikingly, inhibition of GSK3beta activity by chemical inhibitors and its expression by RNA interference targeting GSK3beta induced apoptosis and attenuated proliferation of colon cancer cells in vitro. Our findings demonstrate an unrecognized role of GSK3beta in tumor cell survival and proliferation other than its predicted role as a tumor suppressor, and warrant proposing this kinase as a potential therapeutic target in colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
The glamour and gloom of glycogen synthase kinase-3
Jope, R. S., & Johnson, G. V. W. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.004 · Cited by 1,517
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Blocking Oncogenic Ras Signaling for Cancer Therapy
Adjei, A. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1062 · Cited by 831
GSK3 inhibitors: development and therapeutic potential
Cohen, P., & Goedert, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1415 · Cited by 790
The oncogenic activation of β-catenin
Polakis, P. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80003-3 · Cited by 653
Pharmacological inhibitors of glycogen synthase kinase 3
MEIJER, L., FLAJOLET, M., & GREENGARD, P. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.07.006 · Cited by 584
Emerging concepts in colorectal neoplasia
Jass, J. R., Whitehall, V. L. J., Young, J., & Leggett, B. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.35392 · Cited by 495
Prospective Study of Adult Onset Diabetes Mellitus (Type 2) and Risk of Colorectal Cancer in Women
Hu, F. B., Manson, J. E., Liu, S., Hunter, D., Colditz, G. A., Michels, K. B., Speizer, F. E., & Giovannucci, E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.6.542 · Cited by 423
The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
Gatenby, R. A., & Gawlinski, E. T. (2003) · PubMed · Cited by 364
Sharma, M., Chuang, W. W., & Sun, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201919200 · Cited by 308
Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes
Schwabe, R. F., & Brenner, D. A. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00016.2002 · Cited by 231
Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines
Gayet, J., Zhou, X.-P., Duval, A., Rolland, S., Hoang, J.-M., Cottu, P., & Hamelin, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204611 · Cited by 186
Associations Among -TrCP, an E3 Ubiquitin Ligase Receptor, -Catenin, and NF- B in Colorectal Cancer
Ougolkov, A., Zhang, B., Yamashita, K., Bilim, V., Mai, M., Fuchs, S. Y., & Minamoto, T. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh219 · Cited by 164
Self-citationInsulin Resistance and Its Contribution to Colon Carcinogenesis
Komninou, D., Ayonote, A., Richie, J. P., & Rigas, B. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800410 · Cited by 156
Oncogenic β-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer
Ougolkov, A. V., Yamashita, K., Mai, M., & Minamoto, T. (2002) · Gastroenterology · doi:10.1053/gast.2002.30306 · Cited by 147
Self-citationRole of glycogen synthase kinase-3 in cancer: Regulation by Wnts and other signaling pathways
Manoukian, A. S., & Woodgett, J. R. (2002) · Advances in cancer research · doi:10.1016/s0065-230x(02)84007-6 · Cited by 143
Liao, X., Zhang, L., Thrasher, J. B., Du, J., & Li, B. (2003) · PubMed · Cited by 137
Mazor, M., Kawano, Y., Zhu, H., Waxman, J., & Kypta, R. M. (2004) · Oncogene · doi:10.1038/sj.onc.1208068 · Cited by 136
Conformation-dependent phosphorylation of p53
Adler, V., Pincus, M. R., Minamoto, T., Fuchs, S. Y., Bluth, M. J., Brandt‐Rauf, P. W., Friedman, F. K., Robinson, R. C., Chen, J., Wang, X. W., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1686 · Cited by 120
Self-citationCancer morbidity in psychiatric patients: influence of lithium carbonate treatment
Cohen, Y., Chetrit, A., Cohen, Y., Sirota, P., & Modan, B. (1998) · Medical Oncology · doi:10.1007/bf02787342 · Cited by 109
Dihlmann, S., Klein, S., & Mv, M. V. K. D. (2003) · PubMed · Cited by 108
GSK3β Signalling: Casting a Wide Net in Alzheimer’s Disease
Bhat, R. V., & Budd, S. L. (2002) · Neurosignals · doi:10.1159/000067423 · Cited by 97
Wang, L., Lin, H.-K., Hu, Y., Xie, S., Yang, L., & Chang, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313963200 · Cited by 96
Cited by
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshita, T., Saito, N., Ochiai, A., Tomita, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4806 · Cited by 956
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774
GSK-3 as potential target for therapeutic intervention in cancer
McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Sokolosky, M., Abrams, S. L., Montalto, G., D’Assoro, A. B., Libra, M., Nicoletti, F., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2037 · Cited by 508
Metadata
- Authors
- Shakoori, A., Ougolkov, A., Yu, Z. W., Zhang, B., Modarressi, M. H., Billadeau, D. D., Mai, M., Takahashi, Y., & Minamoto, T.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 334
- Issue
- 4
- Pages
- 1365-1373
- ISSN
- 0006-291X
- OpenAlex
- W1997224330
- Cited by
- 272
- References
- 25
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.